These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 19781577

  • 1. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [Abstract] [Full Text] [Related]

  • 2. A small molecule fusion inhibitor of dengue virus.
    Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W.
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL.
    Cell Chem Biol; 2018 Aug 16; 25(8):1006-1016.e8. PubMed ID: 29937406
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of flavivirus membrane fusion.
    Stiasny K, Fritz R, Pangerl K, Heinz FX.
    Amino Acids; 2011 Nov 16; 41(5):1159-63. PubMed ID: 19882217
    [Abstract] [Full Text] [Related]

  • 5. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
    Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T.
    Antiviral Res; 2010 Nov 16; 88(2):236-43. PubMed ID: 20851716
    [Abstract] [Full Text] [Related]

  • 6. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC, Jang J, Hsia CY, Groomes PV, Lian W, de Wispelaere M, Pitts JD, Wang J, Kwiatkowski N, Gray NS, Yang PL.
    ACS Infect Dis; 2019 Mar 08; 5(3):460-472. PubMed ID: 30608640
    [Abstract] [Full Text] [Related]

  • 7. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
    Parkinson T, Pryde DC.
    Future Med Chem; 2010 Jul 08; 2(7):1181-203. PubMed ID: 21426163
    [Abstract] [Full Text] [Related]

  • 8. Strategies for development of Dengue virus inhibitors.
    Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY.
    Antiviral Res; 2010 Mar 08; 85(3):450-62. PubMed ID: 20060421
    [Abstract] [Full Text] [Related]

  • 9. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
    Lee E, Pavy M, Young N, Freeman C, Lobigs M.
    Antiviral Res; 2006 Jan 08; 69(1):31-8. PubMed ID: 16309754
    [Abstract] [Full Text] [Related]

  • 10. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E, Weir RC, Dalgarno L.
    Virology; 1997 Jun 09; 232(2):281-90. PubMed ID: 9191841
    [Abstract] [Full Text] [Related]

  • 11. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA, Lozach PY, Amara A, Gamarnik AV.
    J Virol; 2007 Jul 09; 81(13):7136-48. PubMed ID: 17459925
    [Abstract] [Full Text] [Related]

  • 12. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M, Singh SK.
    Curr Top Med Chem; 2018 Jul 09; 18(18):1585-1602. PubMed ID: 30360716
    [Abstract] [Full Text] [Related]

  • 13. Antiviral peptides targeting the west nile virus envelope protein.
    Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.
    J Virol; 2007 Feb 09; 81(4):2047-55. PubMed ID: 17151121
    [Abstract] [Full Text] [Related]

  • 14. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL.
    ACS Infect Dis; 2018 Sep 14; 4(9):1395-1406. PubMed ID: 30027735
    [Abstract] [Full Text] [Related]

  • 15. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B, Nougairède A, Wurtz N, Gould E, de Lamballerie X.
    Antiviral Res; 2010 Sep 14; 87(3):281-94. PubMed ID: 20452379
    [Abstract] [Full Text] [Related]

  • 16. The flavivirus polymerase as a target for drug discovery.
    Malet H, Massé N, Selisko B, Romette JL, Alvarez K, Guillemot JC, Tolou H, Yap TL, Vasudevan S, Lescar J, Canard B.
    Antiviral Res; 2008 Oct 14; 80(1):23-35. PubMed ID: 18611413
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel target sites and an inhibitor of the dengue virus E protein.
    Yennamalli R, Subbarao N, Kampmann T, McGeary RP, Young PR, Kobe B.
    J Comput Aided Mol Des; 2009 Jun 14; 23(6):333-41. PubMed ID: 19241120
    [Abstract] [Full Text] [Related]

  • 18. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG.
    Antiviral Res; 2008 Nov 14; 80(2):94-101. PubMed ID: 18674567
    [Abstract] [Full Text] [Related]

  • 19. A structural perspective of the flavivirus life cycle.
    Mukhopadhyay S, Kuhn RJ, Rossmann MG.
    Nat Rev Microbiol; 2005 Jan 14; 3(1):13-22. PubMed ID: 15608696
    [Abstract] [Full Text] [Related]

  • 20. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
    Gao F, Duan X, Lu X, Liu Y, Zheng L, Ding Z, Li J.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):952-7. PubMed ID: 19962368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.